MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,943 | -45.3% | 68,082 | -13.5% | 0.02% | -34.6% |
Q2 2023 | $18,176 | -57.2% | 78,682 | -55.1% | 0.03% | -53.6% |
Q1 2023 | $42,488 | +3094.6% | 175,382 | +3727.6% | 0.06% | +2700.0% |
Q4 2022 | $1,330 | -99.7% | 4,582 | -4.5% | 0.00% | +100.0% |
Q1 2022 | $471,000 | +132.0% | 4,800 | +100.0% | 0.00% | – |
Q4 2021 | $203,000 | -85.1% | 2,400 | -86.0% | 0.00% | -100.0% |
Q3 2021 | $1,365,000 | -73.6% | 17,111 | -67.7% | 0.00% | -66.7% |
Q2 2021 | $5,161,000 | +28.7% | 52,982 | +54.5% | 0.01% | +20.0% |
Q1 2021 | $4,010,000 | +6.0% | 34,282 | +0.7% | 0.01% | +25.0% |
Q4 2020 | $3,783,000 | +46.3% | 34,033 | +56.2% | 0.00% | +33.3% |
Q3 2020 | $2,586,000 | -68.5% | 21,782 | -69.9% | 0.00% | -57.1% |
Q2 2020 | $8,197,000 | +363.6% | 72,382 | +173.3% | 0.01% | +250.0% |
Q1 2020 | $1,768,000 | -78.0% | 26,482 | -69.8% | 0.00% | -77.8% |
Q4 2017 | $8,040,000 | +40.4% | 87,587 | -31.2% | 0.01% | +28.6% |
Q3 2017 | $5,725,000 | +367.0% | 127,287 | +68.8% | 0.01% | +250.0% |
Q2 2017 | $1,226,000 | +37.6% | 75,387 | +30.3% | 0.00% | +100.0% |
Q1 2017 | $891,000 | +4.1% | 57,875 | +0.7% | 0.00% | 0.0% |
Q4 2016 | $856,000 | +27.4% | 57,475 | +8.5% | 0.00% | 0.0% |
Q3 2016 | $672,000 | – | 52,987 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |